FDA Approvals, Fraud Settlements, and Global Health Initiatives: Latest Health News

This health news brief covers significant updates including the FDA's approval of new therapies for multiple sclerosis and eczema, Walgreens' settlement of a prescription billing fraud case, the WHO's new mpox vaccine initiative, China's strategies to boost birth rates, and various other crucial health updates.

The U.S. Food and Drug Administration on Friday approved Roche's new subcutaneous injection to treat multiple sclerosis. This alternative to the IV version could expand treatment options.

Walgreens Boots Alliance will pay $106.8 million to settle prescription billing fraud charges, submitting false claims to Medicare and Medicaid between 2009 and 2020.

The World Health Organization approved a vaccine for mpox and initiated a scheme to improve access for the world's poorest nations, amid a global public health emergency.

China's National Health Commission will advocate for marriage and childbirth at appropriate ages to address declining birth rates.

Eli Lilly's new eczema drug gained FDA approval for use in adults and children over 12 and will be available soon.

Studies discuss mammography findings linked to heart disease and potential benefits of video visits for end-of-life care.

Uganda's mpox cases rise, prompting increased health measures.

Nebraska's highest court allows competing abortion ballot measures for November's election.

Pfizer aims to raise awareness about a rare lung cancer mutation to boost its drug Braftovi.

(With inputs from agencies.)